Snapshot
- A 50-year-old man with a history of HIV presents to his infectious disease clinic for a rash. He reports that he stopped taking his anti-retroviral medication about 2 months ago due to gastrointestinal upset with each dose. He reports feeling well overall but reports developing a painless rash on his legs. Yesterday, he had night sweats and a low-grade fever. On physical exam, there are scattered violaceous papules and plaques on his bilateral lower extremities. Laboratory studies reveal a CD4+ count of < 200/uL. A skin biopsy is taken, and the patient is restarted on antiretrovirals and started on interferon therapy. (Kaposi sarcoma)
Overview
- Drugs
- interferon-α
- interferon-β
- interferon-γ
- Mechanism of action
- interferons are part of the innate host defense against viruses
- they are glycoproteins that are naturally made by virus-infected cells to fight the infection
- interferon upregulates MHC expression
- interferon-α and interferon-β
- downregulates protein synthesis to prevent viral replication
- interferon-γ
- secreted by NK cells and T cells, activating macrophages
- activates NK cells to also eliminate virus-infected cells
- interferons are part of the innate host defense against viruses
- Clinical use
- viral infections, tumors, malignancies, and other conditions
- interferon-α
- hepatitis B
- hepatitis C
- Kaposi sarcoma
- condyloma acuminatum
- hairy cell leukemia
- renal cell carcinoma
- malignant melanoma
- follicular lymphoma
- interferon-β
- multiple sclerosis
- interferon-γ
- chronic granulomatous disease
- osteopetrosis
- Adverse effects
- flu-like symptoms
- neutropenia
- depression
- myopathy
- focal segmental glomerulosclerosis (nephrotic syndrome)